The Future of Cancer Diagnostics

Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes. The company pioneered Multi-Omic Spectral Analysis for the early detection of cancer and validated the test in multiple solid tumor types including brain, colorectal, lung, pancreatic, ovarian, kidney and others.